Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same
AssigneeCell2In, Inc.
InventorsHeunsoo Kang, Ji Woong Shin, Hyewon Kang, Hye Mi Kim, Kibaek Lee, Hatnim Jeon
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition and a kit for assessing the quality of stem cells, and a method for producing stem cells, and may provide a cell therapy product and a composition for preventing or treating immune-related disease.
Claims21
1-15. (canceled)
A method for selection of activated stem cells, the method comprising:
- obtaining stem cells;
- and
- measuring an expression level of a CD71 (Cluster of Differentiation 71) protein or a gene encoding a CD71 protein in the stem cells.
A cell therapy product comprising, as an active ingredient, stem cells exhibiting a CD71low phenotype.
A pharmaceutical composition for preventing or treating an immune-related disease, the pharmaceutical composition comprising, as an active ingredient, stem cells exhibiting a CD71low phenotype.
A composition for assessing quality of stem cells, the composition comprising an agent for measuring an expression level of a CD71 (Cluster of Differentiation 71) protein or a gene encoding a CD71 protein.
Dependencies are inferred from the claim text.